Update: The first of 3,000 actions relating to Actos goes to trial in the U.S.

More details can be found at: https://www.bloomberg.com/news/2013-02-28/takeda-didn-t-warn-of-actos-cancer-risk-lawyer-says.html

CONTACT OUR TEAM TO UNDERSTAND YOUR OPTIONS

Contact our team to understand your options and get clear next steps. Our services are available in English, Bengali, Farsi, French, Greek, Hungarian, Italian, Portuguese, Punjabi and Spanish.